Training Program In The Neurobiology Of Cognition And Cognitive Disorders

描述（由申请人提供）：这是一个有竞争力的更新应用程序在认知和认知障碍的神经生物学在亚拉巴马大学伯明翰分校（C&CD程序）的培训计划。自从C&CD计划于2007年在大卫·斯威特博士的领导下实施以来，UAB在神经科学方面进行了令人印象深刻的投资，认知和认知障碍领域现在被确定为整个机构战略发展的焦点。C&CD计划位于神经生物学系，包括来自医学院（SoM），验光学院和艺术与科学学院11个基础科学和临床部门的47名教师。C&CD计划的目标是培养下一代神经科学研究的领导者和学者，他们：在分子，细胞和认知神经科学理论和研究成果方面有基础;重视使用基础科学发现来理解认知障碍基础的重要性;准备使用创新的研究方法来理解认知和大脑行为关系;并将能够在未来将这些知识转化为认知障碍的治疗和治愈。 C&CD计划在其第一个资助期的成功证明了其强大的参与（35名学生-18名受训人员资助），一个有才华的博士生骨干毕业（10名毕业生-6名资助），平均每个超过四个出版物，所有过渡到有竞争力的博士后职位或完成临床培训。这一更新建立在方案计划的成功组成部分的基础上，提供：（1）细胞、分子、认知和转化神经科学课程;（2）“认知障碍临床评估”课程的临床影子;（3）杰出的研讨会系列;（4）与基础科学和临床导师一起进行论文研究，使用实验方法解决与认知和认知障碍直接相关的问题;以及（5）在务虚会和国家会议上磨练演讲技巧的机会，以及研究道德行为和职业发展方面的指导。C&CD计划的具体“增值”部分包括以患者为导向的研究中的特殊临床/翻译培训经验，与基础科学和临床科学家导师的互动， 和独特的课外活动由于UAB SoM战略计划强调认知和认知疾病是未来五年15名新教师和2000万美元的主要投资领域，C&CD计划的未来是安全的，它将从这项投资中受益匪浅，增加了充满活力的新教师导师和研究设施。

DESCRIPTION (provided by applicant): This is a competitive renewal application for the Training Program in Neurobiology of Cognition and Cognitive Disorders at the University of Alabama at Birmingham (C&CD Program). Since the C&CD Program was implemented in 2007 under the leadership of Dr. David Sweatt, UAB has made an impressive investment in neuroscience with the areas of cognition and cognitive disorders now being identified as a focal point for strategic development across the entire institution. The C&CD Program is housed in the Department of Neurobiology, and includes 47 faculty from 11 basic science and clinical departments in the School of Medicine (SoM), School of Optometry, and College of Arts and Sciences. The goal of the C&CD Program is to develop the next generation of leaders and scholars in neuroscience research who: have a foundation in molecular, cellular, and cognitive neuroscience theories and research findings; value the importance of using findings from basic science to understanding the basis of cognitive disorders; are prepared to use innovative research approaches to understand cognition and brain-behavior relationships; and will be able to translate this knowledge to treatments and cures of cognitive disorders in the future. The success of the C&CD Program in its first funding period is evidenced by its robust participation (35 total students-18 trainees funded), graduation of a talented cadre of doctoral students (ten total graduates-six funded), with an average of more than four publications each, and all transitioning to competitive postdoctoral positions or completing clinical training. This renewal builds on the successful components of the Program Plan by providing: (1) A curriculum with courses in cellular, molecular, cognitive and translational neuroscience; (2) Clinical shadowing in the "Clinical Evaluation of Cognitive Disorders" course; (3) An outstanding seminar series; (4) Dissertation research with both a basic science and clinical mentor, using experimental approaches that address questions with direct relevance to cognition and cognitive disorders; and (5) Opportunities to hone presentation skills at retreats and national meetings, and instruction in ethical conduct of research, and career development. The specific "value added" components of the C&CD Program include the special clinical/translational training experience in patient-oriented research, interactions with both basic science and clinician scientist mentors, and distinct extracurricular activities. As the UAB SoM Strategic Plan highlighted cognition and cognitive diseases as an area for major investment with 15 new faculty and $20 million over the next five years, the future of the C&CD Program is secure and it will benefit substantially from this investment with the addition of dynamic new faculty mentors and research facilities.